Synthesis and antidiabetic activity of some new chromonyl-2,4- thiazolidinediones

Arzneimittel-Forschung/Drug Research

Volumn 57, Issue 8, 2007, Pages 532-536

  Bozdaǧ Dündar, Oya ^a   Ceylan Ünlüsoy, Meltem ^a   Verspohl, Eugen J ^b   Ertan, Rahmiye ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

2,4 Thiazolidinediones; Antidiabetic agents; Chromone; Chromonyl 2,4 thiazolidinediones, antidiabetic activity, synthesis

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 3 (4 BROMOBENZYL) 5 (4 OXO 4H CHROMEN 3 YLMETHYLENE)THIAZOLIDINE 2,4 DIONE; ALDEHYDE; ANTIDIABETIC AGENT; CHROMONE DERIVATIVE; CHROMONYL 2,4 IMIDAZOLIDINEDIONE DERIVATIVE; CHROMONYL 2,4 THIAZOLIDINEDIONE DERIVATIVE; GLIBENCLAMIDE; GLUCOSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; INSULIN LIKE ACTIVITY; INSULIN RELEASE; KNOEVENAGEL CONDENSATION; NONHUMAN; SPECTROSCOPY;

EID: 34548780980     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296644     Document Type: Article

References (16)

1. Sohda T, Momose Y, Meguro K, Kawamatsu Y, Sugiyama Y, Ikeda H. Synthesis and hypoglycemic activity of 5-[4-(pyrid ylalkoxy)benzyl]2,4-thiazolidinediones. Arzneimittel-Forschung (Drug Research). 1990;40:37-42.
2. Iwamoto Y, Kuzuya T, Matsuda A, Awata T, Kumakura S, Inooka G, et al. Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. Diabetes Care. 1991;14:1083-1086.
3. Suter SL, Nolan JJ, Wallace P, Gumbiner B, Olefsky JM. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care. 1992;15:193-203.
4. Bozdaǧ-Dündar O, Verspohl E J, Waheed A, Ertan R. Synthesis and Antidiabetic activity of some new Furochromonyl-2,4-Thiazolidinediones. Arzneimittel-Forschung (Drug Research). 2003;53(12):831-836.
5. Singh G, Singh L, Ishar MPS. 2-(N-methylanilino)-3-formylchromone-a versatile synthon for incorporation of chromone moiety in a variety of heterocyclic systems and macrocycles through reactions with bifunctional nucleophiles. Tetrahedron. 2002;58:7883-7890.
6. DeLima MCA, Costa DLB, Goes AJS, Galdino SL, Pitta IR, Luu-Duc C. Synthesis and antimicrobial activity of chlorobenzyl benzylidene imidazolidine derivatives and substituted thiazolidinediones. Pharmazie. 1992;47:182-184.
7. Lo C, Shropshire EY. The Alkylation of 2,4-Thiazolidinedione. J Org Chem. 1957;22:999-1001.
8. Costa DLB, Chantarel J, DeLima MCA, Albuquerque JFC, Lima RMO, Galdino SL., et al. Imidazolidinediones et thiazolidinediones substituées: synthèse, étude structurale et activité cytotoxique. J Pharm Belg. 1995;50:5-10.
9. Goes AJS, De Lima MCA, Galdino SL, Pitta IR, Luu-Duc C. Synthèse et activité antimicrobienne des fluorobenzyl benzylidene thiazolidinediones et imidazolidinediones substituees. J Pharm Belg. 1991;46:236-240.
10. Albuquerque JFC, Filho JAR, Brandao SSF, Lima MCA, Ximenes EA, Galdino SL, et al. synthesis and antimicrobial activity of substituted imidazolidinediones and thioxoimidazolidinediones. Il Farmaco. 1999;54:77-82.
11. Amorim ELC, Brandao SSF, Cavalcanti COM, Galdino SL, Pitta IR, Luu-Duc C. Synthèse et structure des bromo et nitrobenzyl benzylidène imidazolidinediones et thiazolidinediones substituées. Ann Pharm Franç. 1992;50:103-111.
12. Orazi OO, Corral RA, Schuttenberg H. Substitution in the hydantoin ring.Part VIII. Alkylation. Chem Soc J Perkin Trans I. 1974;219-221.
13. Tan SF, Ang KP, Fong YY. (Z)-and (E)-5-Arylmethylenehydantoins: Spectroscopic properties and configuration assignment. J Chem Soc Perkin Trans II. 1986;12:1941-1944.
14. Vögeli U, Philipsborn W. Structures of addition products of acetylenedicarboxylic acid esters with various dinucleophiles. An application of C, H-spin-coupling constants. Helv Chim Acta. 1978;61:607-617.
15. Albuquerque JFC, Albuquerque A, Azevedo CC, Thomasson F, Galdino SL, Chantarel J, et al. Substituted thiazolidinediones and thioimidazolidinones: synthesis, structural study and pharmacological activity. Pharmazie. 1995,50:387-389.
16. Özgen Ö, Ceylan-Ünlüsoy M, Bozdaǧ-Dündar O, Ertan R, Kendi E. 3-(4-Chloro-benzyl)-5-(4-oxo-4H-chromen-3-yl-methylene) -thiazolidine-2,4-dione.Acta Crystallographica. 2005;E61:870-872.